In all mutations, GRIN2A variants are associated with neurological diseases including developmental and epileptic encephalopathy, which may be manifested as seizures, mild speech and language delay, and cognitive impairment (Lemke et al., 2013, 2014; Fry et al., 2018). This evidence concerns the gene GRIN2A and Cognitive impairment.